LORBRENA (lorlatinib) 3 Serious Warnings And Precautions Box

Medical Information
Canada
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for Canadian Healthcare Professionals. Would you like to proceed?

For Canadian
Healthcare ProfessionalsFor Canadian
Healthcare Professionals
SelectFor Canadian
Healthcare ProfessionalsFor Canadian
Healthcare Professionals
For Canadian
Patients, Consumers or CaregiversNo, go back to the patient portal
SelectFor Canadian
Patients, Consumers or CaregiversNo, go back to the patient portal
Site is intended for Canadian residents. For Non-Canada residents click here.

Serious Warnings and Precautions

  • Hypercholesterolemia / Hypertriglyceridemia (see 7 WARNINGS AND PRECAUTIONS, Metabolism and Endocrine, Hyperlipidemia)
  • Pneumonitis (see 7 WARNINGS AND PRECAUTIONS, Respiratory, ILD/Pneumonitis)
  • Hepatotoxicity (see 7 WARNINGS AND PRECAUTIONS, General, Drug-Drug Interactions, Risk of Serious Hepatotoxicity with Concomitant Use of Strong CYP3A Inducers)

LORBRENA should only be prescribed and supervised by a qualified physician experienced in the use of antineoplastic agents.